Leeward Investments’s Zimmer Biomet ZBH Stock Holding History

Leeward Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.51M	Sell	94,088 -3,241	-3%	-$297K	0.42%	105
2025 Q4	$8.75M	Buy	97,329 +4,529	+5%	+$429K	0.44%	105
2025 Q3	$9.14M	Sell	92,800 -3,340	-3%	-$331K	0.47%	99
2025 Q2	$8.77M	Buy	96,140 +1,853	+2%	+$179K	0.47%	100
2025 Q1	$10.7M	Sell	94,287 -3,293	-3%	-$352K	0.57%	77
2024 Q4	$10.3M	Sell	97,580 -2,836	-3%	-$304K	0.51%	86
2024 Q3	$10.8M	Sell	100,416 -4,985	-5%	-$544K	0.5%	90
2024 Q2	$11.4M	Sell	105,401 -4,782	-4%	-$564K	0.53%	94
2024 Q1	$14.5M	Buy	110,183 +4,227	+4%	+$528K	0.64%	64
2023 Q4	$12.9M	Sell	105,956 -2,858	-3%	-$319K	0.61%	81
2023 Q3	$12.2M	Sell	108,814 -1,186	-1%	-$151K	0.62%	78
2023 Q2	$16M	Sell	110,000 -7,024	-6%	-$955K	0.75%	45
2023 Q1	$15.1M	Buy	117,024 +17,553	+18%	+$2.2M	0.69%	61
2022 Q4	$12.7M	Sell	99,471 -1,214	-1%	-$141K	0.56%	87
2022 Q3	$10.5M	Sell	100,685 -835	-0.8%	-$91.6K	0.5%	94
2022 Q2	$10.7M	Sell	101,520 -865	-0.8%	-$103K	0.49%	96
2022 Q1	$13.1M	Buy	+102,385	New	+$12.3M	0.52%	91

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Leeward Investments's ZBH Position: Q1 2026 in Review

Leeward Investments reduced its Zimmer Biomet (ZBH) stake by 3.3% in Q1 2026, selling an estimated $297K and leaving 94,088 shares worth $8.51M. The position accounts for 0.42% of the portfolio, ranked #105.

Leeward Investments first reported a position in ZBH in Q1 2022 and has held it in 17 quarters since. The position peaked at $16M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Leeward Investments held 94,088 shares of Zimmer Biomet worth $8.51M as of Q1 2026.
Leeward Investments sold 3,241 Zimmer Biomet shares in Q1 2026, an estimated $297K.
Zimmer Biomet made up 0.42% of Leeward Investments's portfolio in Q1 2026, its #105 holding.
Leeward Investments first reported a position in Zimmer Biomet in Q1 2022 and has held it in 17 quarters since.
Leeward Investments's Zimmer Biomet position peaked at $16M in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Leeward Investments's 13F filing for Q1 2026, filed 17 Apr 2026.